Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients

Transplantation

Volumn 66, Issue 12, 1998, Pages 1587-1596

  Li, Wei ^a   Fu, Fumin ^a   Lu, Lina ^a   Narula, Satwant K ^b   Fung, John J ^a   Thomson, Angus W ^a,c   Qian, Shiguang ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT SURVIVAL; HEART TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTOTOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; ANTIBODIES, MONOCLONAL; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-10; ISOANTIBODIES; LIVER TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032573682     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00004     Document Type: Article

References (56)

1. Thomson AW, Starzl TE, eds. Immunosuppressive drugs: developments in anti-rejection therapy. Boston: Little, Brown, 1994.
2. Bejarano MT, de Waal Malefyt R, Abrams IS, et al. Interleukin-10 inhibits allogeneic proliferation and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 1992; 4: 1389.
3. + T-cell clones and T cells: specific inhibition of IL-2 production and proliferation. J Immunol 1993; 150: 4754.
4. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915.
5. Ding L, Linsley PS, Huang L-H, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224.
6. de Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209.
7. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815.
8. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991; 174: 1549.
9. de Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Effects of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 1997; 27: 1229.
10. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Williams F. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol 1997; 27: 1848.
11. Enk AH, Saloga J, Becker D, Mohamadzadeh M, Knop J. Induction of hapten-specific tolerance by IL-10 in vivo. J Exp Med 1994; 179: 1397.
12. Li L, Elliott JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 1994; 153: 3967.
13. Gorczynski RM, Wojcik D. A role for nonspecific (cyclosporine A) or specific (monoclonal antibodies of ICAM-1, LFA-1, and IL-10): immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization of transfusion. J Immunol 1994; 152: 2011.
14. Qin L, Chavin KD, Ding Y, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316.
15. Bacchetta R, Bigler M, Touraine JL, et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179: 493.
16. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169.
17. Wogensen L, Lee M-S, Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379.
18. Wagner RD, Maroushek NM, Brown JF, Czuprynski CJ. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect Immun 1994; 62: 2345.
19. + graft-infiltrating T lymphocytes in promptly rejected kidney allografts. Transplantation 1995; 59: 1113.
20. Xu G-P, Sharma VK, Li B, et al. Intragraft expression of IL-10 messager RNA: a novel correlate of renal allograft rejection. Kidney Int 1995; 48: 1504.
21. Blazar BR, Taylor PA, Smith S, Vallera DA. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood 1995; 85: 842.
22. Berman RM, Suzuki T, Tahara H, Robbins P, Narula SK, Lotze MT. Systemic administration of cellular interleukin-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J Immunol 1996; 157: 231.
23. Qian S, Li W, Li Y, Fu F, Lu L, Fung JJ, Thomson AW. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation 1996; 62: 1709.
24. 1 mice. J Exp Med 1994; 179: 305.
25. Ishida H, Hastings R, Kearney J, Howard M. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 1992; 175: 1213.
26. Denis M, Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 1993; 151: 5425.
27. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
28. Qian S, Fung JJ, Demetris AJ, Ildstad S, Starzl TE. Orthotopic liver transplantation in mice. Transplantation 1991; 52: 562.
29. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
30. Mosmann TR, Schumacher JH, Fiorentino DF, Leverah J, Moore KW, Bond MW. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J Immunol 1990; 145: 2938.
31. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
32. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40L pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64: 1808.
33. Onodera K, Lehmann E, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of "infectious" tolerance to MHC incompatible cardiac allografts in CD4 mAb-treated sensitized rat recipients. J Immunol 1996; 157: 1944.
34. Qian S, Demetris AJ, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
35. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081.
36. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan JTA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRFI. Science 1990; 248: 1230.
37. O'Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2: 821.
38. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178: 2207.
39. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165.
40. Li W, Lu L, Li Y, et al. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in mouse cardiac transplantation. Transplant Proc 1997; 29: 1081.
41. Chapman JR. The sensitized patient. In: Thomson AW, Catto GRD, eds. Immunology of renal transplantation. Boston: Little, Brown, 1993, 235.
42. Forbes RDC, Kuramochi T, Guttmann RD, Klassen J, Knaack J. A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat. Lab Invest 1975; 33: 280.
43. Eichwald EJ, Shelby J. Serum and cell-mediated responses in tolerance and hyperacute rejection of transplanted mouse hearts. Transplantation 1987; 43: 520.
44. Knechtle SJ, Kolbeck PC, Tschimoto S, Coudouiotis A, Sanfilippo F, Bollinger RR. Hepatic transplantation into sensitized recipients: demonstration of hyperacute rejection. Transplantation 1987; 43: 8.
45. Forbes RDC, Guttmann RD, Pinto-Blonde M. A passive transfer model of acute rat cardiac allograft rejection. Lab Invest 1979; 41: 348.
46. Rousset F1 Peyrol S, Garcia E, et al. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol 1995; 7: 1243.
47. +B (B-1) cells by antisense IL-10 oligonucleotide. Leukoc Res 1995; 19: 159.
48. - human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies: effect of IL-10, IL-2 and mode of activation of T cells. Clin Exp Immunol 1995; 101: 369.
49. Rousset F, Peyrol S, Garcia E, et al. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol 1995; 7: 1243.
50. Marcelletti JF, Katz DH. IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation. Cell Immunol 1996; 167: 86.
51. Ishida H, Hastings R, Thompson-Snipes L, Howard M. Modified immunological status of anti-IL-10 treated mice. Cell Immunol 1993; 148: 371.
52. Thai NL Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation: graft rejection is associated with augmented Th1 function. Transplantation 1995; 59: 274.
53. de Waal Malefyt R, Moore KW. Interleukin-10. In: Thomson AW, ed. The cytokine handbook, 3rd ed. San Diego: Academic Press, 1998, 333.
54. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528.
55. Baldwin WM. Alloantibody responses and B lymphocytes. In: Tilney NL Strom TB, Paul LC, eds. Transplantation biology: cellular and molecular aspects. New York: Lippincott-Raven Publishers, 1996, 457.
56. Kupiec-Weglinski JW, Hancock WW. In: Tilney NL, Strom TB, Paul LC, eds. Transplantation biology: cellular and molecular aspects. New York: Lippincott-Raven Publishers, 1996, 541.